These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The Netherlands. Wonderling D, Umans-Eckenhausen MA, Marks D, Defesche JC, Kastelein JJ, Thorogood M. Semin Vasc Med; 2004 Feb; 4(1):97-104. PubMed ID: 15199439 [Abstract] [Full Text] [Related]
11. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia. Ademi Z, Watts GF, Pang J, Sijbrands EJ, van Bockxmeer FM, O'Leary P, Geelhoed E, Liew D. J Clin Lipidol; 2014 Mar; 8(4):390-400. PubMed ID: 25110220 [Abstract] [Full Text] [Related]
16. Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia. Langslet G, Ose L. Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):1061-6. PubMed ID: 23984929 [Abstract] [Full Text] [Related]
17. Clinical, diagnostic, and therapeutic aspects of familial hypercholesterolemia. van Aalst-Cohen ES, Jansen AC, de Jongh S, de Sauvage Nolting PR, Kastelein JJ. Semin Vasc Med; 2004 Feb; 4(1):31-41. PubMed ID: 15199431 [Abstract] [Full Text] [Related]
19. [Cost-effectiveness analysis of a genetic screening program in the close relatives of Spanish patients with familial hypercholesterolemia]. Oliva J, López-Bastida J, Moreno SG, Mata P, Alonso R. Rev Esp Cardiol; 2009 Jan; 62(1):57-65. PubMed ID: 19150015 [Abstract] [Full Text] [Related]
20. Update of the molecular basis of familial hypercholesterolemia in The Netherlands. Fouchier SW, Kastelein JJ, Defesche JC. Hum Mutat; 2005 Dec; 26(6):550-6. PubMed ID: 16250003 [Abstract] [Full Text] [Related] Page: [Next] [New Search]